FDA clears DermaSensor's real-time, skin cancer evaluation system.
FDA extends the shelf life of Emergent BioSolutions newly manufactured Narcan (naloxone HCl) 4 mg nasal spray products from three years to four years....
FDA recommends that the Drug Enforcement Administration down-classify marijuana from Schedule 1 to Schedule 3 under the Controlled Substances Act.
FDA grants Nurix Therapeutics a fast track designation for NX-5948 for treating certain adult patients with relapsed or refractory chronic lymphocytic...
Federal Register notice: FDA revises an information collection entitled Premarket Notification for a New Dietary Ingredient (NDI) 21 CFR 190.6.
FDA warns San Diego, CA-based Dr. Joel Kaplan Inc. about multiple violations in its manufacturing and distribution of several devices intended to enha...
A physician survey conducted by UCSF researchers finds many doctors dont understand how FDA approves new drugs and medical devices.
Hemogenyx Pharmaceuticals files its complete response to an FDA HEMO-CAR-T clinical hold in hopes of starting Phase 1 trials.
